According to the latest report by IMARC Group, titled "Hydrogel Market Report by Raw Material Type (Synthetic, Natural, Hybrid), Form (Amorphous, Semi-crystalline, Crystalline), Composition (Polyacrylate, Polyacrylamide, Silicone-modified Hydrogels (SiH), and Others), Application (Contact Lenses, Personal Care and Hygiene, Wound Care, Drug Delivery, Tissue Engineering, and Others), and Region 2025-2033," the global hydrogel market reached a value of USD 29.1 Billion in 2024. Hydrogel refers to a hydrophilic polymer that is generally utilized in biomedical settings, regenerative medicine and research laboratories. It is usually produced synthetically or derived naturally in the form of polymer networks in gelatin or collagen. Due to its excellent oxygen permeability, water absorption, micro-porous structure, increased suction and tissue-like physical properties, it is gaining widespread prominence across the hygiene and personal care segment. Since there has been a considerable increase in the awareness regarding menstrual hygiene, this is providing a boost to the market growth.
Global Hydrogel Market Trends:
The global market is primarily driven by the increasing product demand across the pharmaceutical industry. In line with this, the rising utilization of hydrogel in the administration of drugs, burn treatment and wound dressings are creating a positive outlook for the market. Since hydrogels exhibit unique biocompatibility and desirable physical characteristics, there has been a considerable increase in the adoption of the product as scaffolds to provide structural integrity for cellular organization, act as drug depots and serve as tissue bio adhesives and barriers. Along with this, the escalating utilization of hydrogels in the production of tampons and sanitary pads for enhanced absorbency is providing a boost to the market. Furthermore, the widespread adoption of hydrogels in the manufacturing of soft robotic designs due to their transparency, high stretchability and ion conductivity is significantly driving the growth of the market. Other factors, including the rising healthcare expenditure, the increasing prevalence of chronic illnesses, the growing number of research centers and extensive research and development (R&D) activities conducted by key players, are further contributing to the market growth. On account of the aforementioned factors, the market is anticipated to reach a value of USD 44.4 Billion by 2033, growing at a CAGR of 4.8% during 2025-2033.
Market Summary:
Report Features | Details |
---|---|
Base Year of the Analysis | 2024 |
Historical Period | 2019-2024 |
Forecast Period | 2025-2033 |
Units | Billion USD |
Segment Coverage | Raw Material Type, Form, Composition, Application, Region |
Region Covered | Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
Countries Covered | United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
Companies Covered | 3M Company, Ashland Global Holdings Inc., B. Braun Melsungen AG, Cardinal Health Inc., Coloplast A/S, Essity AB, Evonik Industries AG, Hoya Corporation, Integra LifeSciences, Johnson & Johnson, Koninklijke DSM N.V., Medline Industries Inc., Medtronic plc, Smith & Nephew plc and The Cooper Companies Inc. |
Customization Scope | 10% Free Customization |
Post-Sale Analyst Support | 10-12 Weeks |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1 631 791 1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800